Search

Search bills, members, committees and pages...

H.R. 4709

U.S. HouseIn House Committee

Summary

H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act of 2025, was introduced in the House on Jul 23, 2025 by Rep. Kelly Morrison (D) with 7 co-sponsors. It last saw action on Sep 10, 2025: Forwarded by Subcommittee to Full Committee by Voice Vote.


Record

Text

H.R. 4709 has 7 co-sponsors.

hb4709/introduced-in-house.txt
119 HR 4709 IH: Newborn Screening Saves Lives Reauthorization Act of 2025
U.S. House of Representatives
2025-07-23
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 4709 IN THE HOUSE OF REPRESENTATIVES July 23, 2025 Ms. Morrison (for herself, Mr. Simpson , Ms. Schrier , and Mr. Langworthy ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To amend the Public Health Service Act to reauthorize certain programs under part A of title XI of such Act relating to genetic diseases, and for other purposes.
1.
Short title
This Act may be cited as the Newborn Screening Saves Lives Reauthorization Act of 2025 .
2.
Improved newborn and child screening and follow-up for heritable disorders
(a)
Purposes
Section 1109(a) of the Public Health Service Act ( 42 U.S.C. 300b–8(a) ) is amended—
(1)
in paragraph (1), by striking enhance, improve or and inserting facilitate, enhance, improve, or ;
(2)
by amending paragraph (3) to read as follows:
(3)
to develop, and deliver to parents, families, and patient advocacy and support groups, educational programs that—
(A)
address newborn screening counseling, testing (including newborn screening pilot studies), follow-up, treatment, specialty services, and long-term care;
(B)
assess the target audience’s current knowledge, incorporate health communications strategies, and measure impact; and
(C)
are at appropriate literacy levels;
; and
(3)
in paragraph (4)—
(A)
by striking followup and inserting follow-up ; and
(B)
by inserting before the semicolon at the end the following: , including re-engaging patients who have not received recommended follow-up services and supports .
(b)
Approval factors
Section 1109(c) of the Public Health Service Act ( 42 U.S.C. 300b–8(c) ) is amended—
(1)
by striking or will use and inserting will use ; and
(2)
by inserting , or will use amounts received under such grant to enhance capacity and infrastructure to facilitate the adoption of, before the guidelines and recommendations .
3.
Advisory committee on heritable disorders in newborns and children
Section 1111 of the Public Health Service Act ( 42 U.S.C. 300b–10 ) is amended—
(1)
in subsection (b)—
(A)
in paragraph (5), by inserting and adopt process improvements after take appropriate steps ;
(B)
in paragraph (7) by striking and at the end;
(C)
by redesignating paragraph (8) as paragraph (9);
(D)
by inserting after paragraph (7) the following:
(8)
develop, maintain, and publish on a publicly accessible website consumer-friendly materials detailing—
(A)
the uniform screening panel nomination process, including data requirements, standards, and the use of international data in nomination submissions; and
(B)
the process for obtaining technical assistance for submitting nominations to the uniform screening panel and detailing the instances in which the provision of technical assistance would introduce a conflict of interest for members of the Advisory Committee; and
; and
(E)
in paragraph (9), as redesignated—
(i)
by redesignating subparagraphs (K) and (L) as subparagraphs (L) and (M), respectively; and
(ii)
by inserting after subparagraph (J) the following:
(K)
the appropriate and recommended use of safe and effective genetic testing by health care professionals in newborns and children with an initial diagnosis of a disease or condition characterized by a variety of genetic causes and manifestations;
; and
(2)
in subsection (g)—
(A)
in paragraph (1) by striking 2019 and inserting 2030 ; and
(B)
in paragraph (2) by striking 2019 and inserting 2030 .
4.
Clearinghouse of newborn screening information
Section 1112(c) of the Public Health Service Act ( 42 U.S.C. 300b–11(c) ) is amended by striking and supplement, not supplant, existing information sharing efforts and inserting and complement other Federal newborn screening information sharing activities .
5.
Laboratory quality and surveillance
Section 1113 of the Public Health Service Act ( 42 U.S.C. 300b–12 ) is amended—
(1)
in subsection (a)—
(A)
in paragraph (1)—
(i)
by striking performance evaluation services, and inserting development of new screening tests, ; and
(ii)
by striking and at the end;
(B)
in paragraph (2)—
(i)
by striking performance test materials and inserting test performance materials ; and
(ii)
by striking the period at the end and inserting ; and ; and
(C)
by adding at the end the following:
(3)
performance evaluation services to enhance disease detection, including the development of tools, resources, and infrastructure to improve data analysis, test result interpretation, data harmonization, and dissemination of laboratory best practices.
; and
(2)
in subsection (b) to read as follows:
(b)
Surveillance activities
The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 1111, shall provide for the coordination of national surveillance activities, including—
(1)
standardizing data collection and reporting through the use of electronic and other forms of health records to achieve real-time data for tracking and monitoring the newborn screening system, from the initial positive screen through diagnosis and long-term care management; and
(2)
by promoting data sharing linkages between State newborn screening programs and State-based birth defects and developmental disabilities surveillance programs to help families connect with services to assist in evaluating long-term outcomes.
.
6.
Hunter Kelly research program
Section 1116 of the Public Health Service Act ( 42 U.S.C. 300b–15 ) is amended—
(1)
in subsection (a)(1)—
(A)
by striking may and inserting shall ; and
(B)
in subparagraph (D)—
(i)
by inserting , or with a high probability of being recommended by, after recommended by ; and
(ii)
by striking that screenings are ready for nationwide implementation and inserting that reliable newborn screening technologies are piloted and ready for use ; and
(2)
in subsection (b) to read as follows:
(b)
Funding
In carrying out the research program under this section, the Secretary and the Director shall ensure that entities receiving funding through the program will provide assurances, as practicable, that such entities will work in consultation with State departments of health, as appropriate.
.
7.
Authorization of appropriations for newborn screening programs and activities
Section 1117 of the Public Health Service Act ( 42 U.S.C. 300b–16 ) is amended—
(1)
in paragraph (1)—
(A)
by striking $11,900,000 and inserting $20,883,000 ;
(B)
by striking 2015 and inserting 2026 ; and
(C)
by striking 2019 and inserting 2030 ; and
(2)
in paragraph (2)—
(A)
by striking $8,000,000 and inserting $22,250,000 ;
(B)
by striking 2015 and inserting 2026 ; and
(C)
by striking 2019 and inserting 2030 .
8.
Institutional review boards; ethics guidance program
Section 12 of the Newborn Screening Saves Lives Reauthorization Act of 2014 ( 42 U.S.C. 289 note) is amended to read as follows:
12.
Institutional review boards; ethics guidance program
Research on nonidentified newborn dried blood spots shall be considered secondary research (as that term is defined in section 46.104(d)(4) of title 45, Code of Federal Regulations (or successor regulations)) with nonidentified biospecimens for purposes of federally funded research conducted pursuant to the Public Health Service Act ( 42 U.S.C. 200 et seq. ).
.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-07-23
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Jul 23, 2025

hb4709/introduced-in-house.md

Shown Here:
Introduced in House (07/23/2025)

Newborn Screening Saves Lives Reauthorization Act of 2025

This bill reauthorizes through FY2030 and revises several programs and activities relating to newborn screening for certain conditions and diseases.

Among its changes, the bill reauthorizes and makes mandatory

  • the Hunter Kelly Research Program at the National Institutes of Health, and
  • national surveillance activities conducted by the Centers for Disease Control and Prevention.

The bill also provides statutory authority for current regulations that exempt federally funded research on non-identified newborn blood spots (i.e., residual blood samples used to screen for serious conditions) from regulations that govern research on human subjects.

Sponsors

Rep. Kelly Morrison (D) sponsors H.R. 4709, and 7 members have co-sponsored it, 3 of them from the day it was introduced.

Committees

H.R. 4709 went before 2 committees: Health Subcommittee and Energy and Commerce.

Health Subcommittee
Health Subcommittee
Reported by · Sep 10, 2025 · 143 Bills
Energy and Commerce
Energy and Commerce
Referred To · Jul 23, 2025 · 1,636 Bills

Actions

H.R. 4709 has taken 5 actions since Jul 23, 2025, the latest on Sep 10, 2025.

ChamberAction
Sep 10, 2025
House
Referred to the Subcommittee on Health.Health Subcommittee
Sep 10, 2025
House
Subcommittee Consideration and Mark-up Session HeldHealth Subcommittee
Sep 10, 2025
House
Forwarded by Subcommittee to Full Committee by Voice Vote.Health Subcommittee
Jul 23, 2025
House
Introduced in House
Jul 23, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 4709 has not gone to a roll call.

Titles

H.R. 4709 goes by 3 titles, 1 of them short titles.

  • Newborn Screening Saves Lives Reauthorization Act of 2025 — Display Title
  • To amend the Public Health Service Act to reauthorize certain programs under part A of title XI of such Act relating to genetic diseases, and for other purposes. — Official Title as Introduced
  • Newborn Screening Saves Lives Reauthorization Act of 2025 — Short Title(s) as Introduced

Lobbying

12 clients hired 12 firms and 24 registered lobbyists who named H.R. 4709 in 34 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Education, Labor Issues/Antitrust/Workplace, Pharmacy.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
GENEDX, LLCHealth Care DiagnosticsConnecticut14$320K
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERSNational professional association for pediatric nurse practitionersNew Jersey14$96K
AMERICAN COLLEGE OF MEDICAL GENETICS14$80K
AMERICAN ACADEMY OF PEDIATRICSIllinois14
EVERYLIFE FOUNDATION FOR RARE DISEASESDistrict of Columbia14
TRAVERE THERAPEUTICSBiopharmaceuticalsCalifornia14
REVVITY, INC.Massachusetts13
NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATIONDistrict of Columbia12
STEALTH BIOTHERAPEUTICS INC.Developing therapies to treat mitochondrial dysfunction.Massachusetts12
ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)District of Columbia11
BEREN THERAPEUTICSBiotech/biopharmaceutical companiesCalifornia11
MUSCULAR DYSTROPHY ASSOCIATION, INC.Illinois11

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 24.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
AMERICAN ACADEMY OF PEDIATRICSAMERICAN ACADEMY OF PEDIATRICS2026 second_quarter$789.3K2nd Quarter - Report
AMERICAN ACADEMY OF PEDIATRICSAMERICAN ACADEMY OF PEDIATRICS2026 first_quarter$320K1st Quarter - Report
AMERICAN ACADEMY OF PEDIATRICSAMERICAN ACADEMY OF PEDIATRICS2025 third_quarter$300K3rd Quarter - Report
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2025 fourth_quarter$260K4th Quarter - Report
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2026 first_quarter$200K1st Quarter - Report
NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATIONTHE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION2026 first_quarter$150K1st Quarter - Report
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2026 second_quarter$140K2nd Quarter - Report
NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATIONTHE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION2026 second_quarter$140K2nd Quarter - Report
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2026 second_quarter$120K2nd Quarter - Report
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2026 first_quarter$120K1st Quarter - Report
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2025 third_quarter$110K3rd Quarter - Report
AMERICAN ACADEMY OF PEDIATRICSAMERICAN ACADEMY OF PEDIATRICS2025 fourth_quarter$100K4th Quarter - Report
GENEDX, LLCRED+BLUE STRATEGIES2026 second_quarter$80K2nd Quarter - Report
GENEDX, LLCRED+BLUE STRATEGIES2026 first_quarter$80K1st Quarter - Report
GENEDX, LLCRED+BLUE STRATEGIES2025 fourth_quarter$80K4th Quarter - Report
GENEDX, LLCRED+BLUE STRATEGIES2025 third_quarter$80K3rd Quarter - Report
EVERYLIFE FOUNDATION FOR RARE DISEASESEVERYLIFE FOUNDATION FOR RARE DISEASES2026 first_quarter$70K1st Quarter - Report
EVERYLIFE FOUNDATION FOR RARE DISEASESEVERYLIFE FOUNDATION FOR RARE DISEASES2025 third_quarter$60K3rd Quarter - Report
MUSCULAR DYSTROPHY ASSOCIATION, INC.MUSCULAR DYSTROPHY ASSOCIATION, INC.2025 third_quarter$50K3rd Quarter - Report
EVERYLIFE FOUNDATION FOR RARE DISEASESEVERYLIFE FOUNDATION FOR RARE DISEASES2026 second_quarter$40K2nd Quarter - Report

Classification

The Congressional Research Service files H.R. 4709 under Health, one of its 31 policy areas, and gives it 11 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 4709’s is Health.

hr4709/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 4709 carries 11 of CRS’s legislative subjects, from Advisory bodies to Research administration and funding.

hr4709/subjects.txt
Advisory bodiesChild healthData collection, sharing, protectionDrug safety, medical device, and laboratory regulationGeneticsGovernment information and archivesHereditary and development disordersMedical researchMedical tests and diagnostic methodsPerformance measurementResearch administration and funding

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 4709, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 126 (Wednesday, July 23, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. MORRISON:H.R. 4709.Congress has the power to enact this legislation pursuantto the following:Section 1 of Article 1 of the Constitution: All legislativePowers herein granted shall be vested in a Congress of theUnited States, which shall consist of a Senate and House ofRepresentatives.[Page H3649]

Source: congress.gov · legiscan.com